Unknown PHASE2 INTERVENTIONAL 2-arm NCT01489267

A New Method to Treat Hereditary Cerebellar Ataxia - Umbilical Cord Mesenchymal Stem Cells Transplantation (SCA)

The Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cells Transplantation in Hereditary Cerebellar Ataxia Patients

Sponsor: General Hospital of Chinese Armed Police Forces

Conditions Hereditary Cerebellar Ataxia.

Interventions stem cell transplantation

Updated 6 times since 2017 Last updated: Jun 18, 2012 Started: Dec 31, 2011 Primary completion: Jul 31, 2013 Completion: Jul 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Hereditary Cerebellar Ataxia., this trial is ongoing. The trial is conducted by General Hospital of Chinese Armed Police Forces and has accumulated 6 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2
Feb 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

Status: Enrolling By Invitation → Unknown Status

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Enrolling By Invitation PHASE2

First recorded

Dec 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

General Hospital of Chinese Armed Police Forces

Data source: General Hospital of Chinese Armed Police Forces

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China